Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response Patterns to Treatment in Glioblastoma (GBM) Oncology Patients Based on Host Response Evaluation During Anti-cancer Treatments

NCT04219475 is registered in ClinicalTrials.gov with OncoHost Ltd. as lead sponsor.

NCT NCT04219475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response Patterns to Treatment in Glioblastoma (GBM) Oncology Patients Based on Host Response Evaluation During Anti-cancer Treatments
Lead sponsor
OncoHost Ltd.
Phase
Observational
Overall status
Suspended
Start date
January 31, 2023
Completion date
December 31, 2025
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma